Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia, USA.
Tissue Eng Part A. 2013 Jan;19(1-2):1-13. doi: 10.1089/ten.TEA.2012.0085. Epub 2012 Aug 21.
Skeletal injuries are among the most prevalent clinical problems and bone marrow-derived mesenchymal stem/stromal cells (BMSCs) have successfully been used for the treatment thereof. Stromal cell-derived factor-1 (SDF-1; CXCL12) is a member of the CXC chemokine family with multiple splice variants. The two most abundant variants, SDF-1α and SDF-1β, share identical amino acid sequences, except for four additional amino acids at the C-terminus of SDF-1β, which may mediate surface stabilization via glycosaminoglycans and protect SDF-1β from proteolytic cleavage, rendering it twice as potent as SDF-1α. Increasing evidence suggests that SDF-1 is involved in bone formation through regulation of recruitment, engraftment, proliferation, and differentiation of stem/progenitor cells. The underlying molecular mechanisms, however, have not yet been fully elucidated. In this study, we tested the hypothesis that SDF-1β can potentiate bone morphogenetic protein-2 (BMP-2)-stimulated osteogenic differentiation and chemotaxis of BMSCs in vitro. Utilizing retrovirus-mediated gene transfer to generate novel Tet-Off-SDF-1β BMSCs, we found that conditional SDF-1β expression is tightly regulated by doxycycline in a dose-dependent and temporal fashion, leading to significantly increased SDF-1β mRNA and protein levels. In addition, SDF-1β was found to enhance BMP-2-stimulated mineralization, mRNA and protein expression of key osteogenic markers, and regulate BMP-2 signal transduction via extracellular signal-regulated kinases 1/2 (Erk1/2) phosphorylation in genetically engineered BMSCs in vitro. We also showed that SDF-1β promotes the migratory response of CXC chemokine receptor 4 (CXCR4)-expressing BMSCs in vitro. Taken together, these data support that SDF-1β can play an important role in BMP-2-stimulated osteogenic differentiation of BMSCs and may exert its biological activity in both an autocrine and paracrine fashion.
骨骼损伤是最常见的临床问题之一,骨髓间充质干细胞(BMSCs)已成功用于治疗此类问题。基质细胞衍生因子-1(SDF-1;CXCL12)是趋化因子家族的一员,具有多种剪接变体。两种最丰富的变体,SDF-1α和 SDF-1β,具有相同的氨基酸序列,除了 SDF-1β 的 C 末端有四个额外的氨基酸,这可能通过糖胺聚糖介导表面稳定并保护 SDF-1β免受蛋白水解切割,使其比 SDF-1α 强两倍。越来越多的证据表明,SDF-1 通过调节干细胞/祖细胞的募集、植入、增殖和分化参与骨形成。然而,其潜在的分子机制尚未完全阐明。在这项研究中,我们检验了 SDF-1β 可以增强骨形态发生蛋白-2(BMP-2)刺激的骨髓间充质干细胞体外成骨分化和趋化作用的假设。利用逆转录病毒介导的基因转移生成新型 Tet-Off-SDF-1β BMSCs,我们发现 SDF-1β 的条件表达受多西环素的剂量依赖性和时间依赖性调节,导致 SDF-1β mRNA 和蛋白水平显著增加。此外,SDF-1β 被发现增强 BMP-2 刺激的矿化、关键成骨标志物的 mRNA 和蛋白表达,并通过细胞外信号调节激酶 1/2(Erk1/2)磷酸化调节基因工程 BMSCs 中的 BMP-2 信号转导。我们还表明,SDF-1β 促进 CXCR4 表达的 BMSCs 的迁移反应。总之,这些数据表明 SDF-1β 在 BMP-2 刺激的 BMSCs 成骨分化中可以发挥重要作用,并且可能以自分泌和旁分泌的方式发挥其生物学活性。